Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology ADCC platform: what are the key features

Author:

InnoModels

Release time:

2024-07-09

With the rapid development of the biopharmaceutical field, the importance of antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism in tumor immunotherapy has become increasingly prominent. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, of which the ADCC platform has been widely recognized by the industry for its unique features and advantages. This article will introduce the main features of ADCC platform.
1、Diversified experimental service system
The ADCC platform of InnoModels has a diversified experimental service system, which can support the combination experiments of various types of tumor cells and immune cells. Whether it is tumor cell lines, primary tumor cells or genetically engineered cell lines, the platform can provide corresponding experimental conditions and technical support. This diversity provides a wide selection space for researchers to choose the most suitable cell type according to specific research needs.
2. Realistic simulation environment
In terms of experimental design, InnoModels' ADCC platform focuses on simulating the in vivo environment to more realistically reflect the actual situation of the ADCC process. The platform adopts advanced cell culture technology and flow cytometry technology, which can monitor and record the changes of cells in real time during the experimental process, effectively differentiate the target cells, count and calculate the proportion of apoptotic cells. This real simulation environment makes the experimental results more valuable and provides researchers with accurate and reliable data support.
3. Highly customizable
InnoModels' ADCC platform is highly customizable and can be tailored to the specific needs of researchers. This includes various aspects such as cell type, drug treatment, and experiment time. This flexibility enables the platform to meet the diverse needs of different researchers, providing powerful technical support for biomedical research.

4. Efficient Data Processing Capability
Equipped with an advanced data analysis system, the platform is able to automate the processing and analysis of experimental data, greatly improving the efficiency and accuracy of data processing. Researchers can understand the experimental results intuitively through the visualization report provided by the platform, so as to better guide the subsequent research work.
5、Professional technical team
The core team of InnoModels Biotechnology ADCC platform consists of a group of senior entrepreneurs, investors and professional managers in the industry, with rich experience in R&D, management, entrepreneurship, investment and capital operation. They have been working in the biomedical field for many years, and have in-depth understanding and rich practical experience in ADCC mechanism. This provides a solid guarantee for the stable operation of the platform and the reliability of the experimental results.
6、Extensive cooperation and communication
Focusing on communication and cooperation with industry peers, InnoModels Biotechnology actively participates in various academic conferences and seminars to share the latest research results and technological advances. At the same time, the platform has also established good cooperative relationships with famous enterprises and research institutions at home and abroad to jointly promote the development of the biomedical field.
In summary, with its diverse experimental services, realistic simulation environment, high customizability, efficient data processing capability and professional technical team, the InnoModels Biotechnology ADCC platform provides powerful technical support for biomedical research. In the future, with the continuous development of the biomedical field, the InnoModels Biotechnology ADCC platform will play a greater role in promoting the progress of biomedical research.

InnoModels Biotechnology PDC High-Throughput In Vitro Drug Efficacy Platform: Introduction of Technical Advantages

What is unique about the InnoModels Biotechnology CDX platform?

InnoModels Biotechnology PDC High-Throughput In Vitro Drug Efficacy Platform: Introduction of Technical Advantages

What is unique about the InnoModels Biotechnology CDX platform?

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License